UBS Downgrades Nuvei to Neutral, Raises Price Target to $34
Portfolio Pulse from Benzinga Newsdesk
UBS analyst Timothy Chiodo downgraded Nuvei (NASDAQ:NVEI) from Buy to Neutral but raised the price target from $30 to $34.

April 03, 2024 | 12:16 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
UBS downgraded Nuvei from Buy to Neutral, but increased the price target from $30 to $34.
The downgrade to Neutral suggests a more cautious outlook on Nuvei's stock by UBS, potentially due to perceived limitations in the stock's upside or emerging risks. However, the increase in the price target from $30 to $34 indicates a positive adjustment in the expected stock value, suggesting that while the stock might not outperform, it is still expected to grow in value. This mixed signal could lead to short-term uncertainty among investors, balancing out potential positive and negative impacts on the stock price.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100